These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35690246)
1. Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy. Tan Y; Liu Q; Li Z; Yang S; Cui L Autoimmun Rev; 2022 Aug; 21(8):103130. PubMed ID: 35690246 [TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome. Tan Y; Liu Q; Li Z; Yang S; Cui L Front Immunol; 2023; 14():1155222. PubMed ID: 37063905 [TBL] [Abstract][Full Text] [Related]
3. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C Front Immunol; 2019; 10():764. PubMed ID: 31040845 [TBL] [Abstract][Full Text] [Related]
4. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
5. Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome. Feng W; Qiao J; Tan Y; Liu Q; Wang Q; Yang B; Yang S; Cui L Front Immunol; 2024; 15():1361519. PubMed ID: 39044818 [TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges. Štok U; Čučnik S; Sodin-Šemrl S; Žigon P Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925261 [TBL] [Abstract][Full Text] [Related]
7. High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome. Liu Q; Yang S; Tan Y; Cui L Front Immunol; 2023; 14():1128245. PubMed ID: 37275905 [TBL] [Abstract][Full Text] [Related]
8. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
9. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome. Álvarez D; Morales-Prieto DM; Cadavid ÁP Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome and pregnancy. Satta R; Biondi G G Ital Dermatol Venereol; 2019 Jun; 154(3):277-285. PubMed ID: 30375212 [TBL] [Abstract][Full Text] [Related]
11. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119 [TBL] [Abstract][Full Text] [Related]
12. [Application progress of high-throughput sequencing in antiphospholipid syndrome]. Liu Q; Yang S; Cui LY Zhonghua Yu Fang Yi Xue Za Zhi; 2023 May; 57(5):766-770. PubMed ID: 37165825 [TBL] [Abstract][Full Text] [Related]
13. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Forastiero R; Martinuzzo M Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051 [TBL] [Abstract][Full Text] [Related]
14. Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review. Cheng C; Cheng GY; Denas G; Pengo V Blood Rev; 2021 Jul; 48():100788. PubMed ID: 33341301 [TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS". Misasi R; Longo A; Recalchi S; Caissutti D; Riitano G; Manganelli V; Garofalo T; Sorice M; Capozzi A Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182499 [TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome. Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571 [TBL] [Abstract][Full Text] [Related]
17. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome. Khamashta M; Taraborelli M; Sciascia S; Tincani A Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):133-48. PubMed ID: 27421221 [TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid syndrome: diagnosis and management]. Ieko M Rinsho Ketsueki; 2021; 62(5):445-455. PubMed ID: 34108328 [TBL] [Abstract][Full Text] [Related]
20. Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome. Patsouras MD; Karagianni P; Kogionou P; Vlachoyiannopoulos PG J Autoimmun; 2019 Aug; 102():159-166. PubMed ID: 31103268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]